Myocardial scar and insulin resistance predict cardiovascular events in severe ischaemic myocardial dysfunction: a perfusion-metabolism positron emission tomography study

被引:6
|
作者
Feola, Mauro [1 ]
Biggi, Alberto [2 ]
Chauvie, Stephane [2 ]
Vado, Antonello [1 ]
Leonardi, Giovanni [1 ]
Rolfo, Fabrizio [1 ]
Ribichini, Flavio [3 ]
机构
[1] Osped Santa Croce Carle, Dept Cardiovasc Dis, I-12100 Cuneo, Italy
[2] Osped Santa Croce Carle, Nucl Med Serv, I-12100 Cuneo, Italy
[3] Univ Verona, Div Cardiol, I-37100 Verona, Italy
关键词
insulin resistance; ischaemic myocardial dysfunction; myocardial positron emission tomography; non-viable myocardium;
D O I
10.1097/MNM.0b013e3282f5d2bc
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background Clinical outcome can be predicted by metabolism-perfusion positron emission tomography (PET) in patients with severe ischaemic left ventricular dysfunction. This study determined whether the amount of viable or non-viable myocardium detected with a PET scan or clinical-functional parameters might predict cardiovascular events. Methods All patients had previous myocardial infarction (> 6 months previously) and left ventricular ejection fraction (LVEF) < 40%. Metabolism-perfusion PET, echocardiogram and coronary angiography were provided. All subjects underwent short euglycaemic-hyperinsulinaemic clamp before the metabolism study. The dysfunctioning segment was defined as hibernating myocardium when metabolism was normal-moderately reduced with impaired perfusion (mismatch flow-metabolism). Cardiac death, hospital admission for myocardial infarction or heart failure were considered cardiovascular events. Results Ninety-three patients (71 males, aged 64.2 years) were studied. The LVEF was 30.2 +/- 7.7%; 48 (51.6%) suffered an anterior myocardial infarction. Fifty-three (54.1%) subjects were treated with coronary revascularization; all had optimal medical therapy. Cardiovascular events occurred in 20/93 patients at 1-year follow-up (event group). Age (P=0.7), diabetes mellitus (P=0.6) and rate of coronary revascularization (P=0.3) were not different in the two groups. Patients who experienced cardiovascular events had larger non-viable myocardium (5.8 +/- 2.7 vs. 4.1 +/- 2.6, P = 0.01), lower metabolic rate glucose (1.3 +/- 0.6 vs. 1.7 +/- 0.7 ml . kg(-1).min(-1), P = 0.04) but similar hibernating myocardium (1.6 +/- 1.6 vs. 1.7 +/- 2, P= 0.8) and baseline LVEF (28.1 +/- 4.8 vs. 30.7 +/- 8.3%, P= 0.08). Having more then five non-viable segments and a metabolic rate for glucose of < 0.9 mg - kg(-1).min(-1) predicted a worse prognosis (P=0.04, log rank, 3.89; and P=0.004, log rank, 8.1, respectively). Conclusion Non-viable myocardium revealed with PET predicts mid-term clinical prognosis. Insulin resistance seems to influence the outcome.
引用
收藏
页码:448 / 454
页数:7
相关论文
共 50 条
  • [1] Myocardial scar and insulin resistance predict cardiovascular events in severe ischemic myocardial dysfunction. A perfusion/metabolism positron emission tomography study
    Feola, M.
    Leonardi, G.
    Peano, S.
    Chauvie, S.
    Rosso, G. L.
    Rolfo, F.
    Bianchi, A.
    Biggi, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2007, 6 : 135 - 136
  • [2] Positron emission tomography myocardial perfusion and glucose metabolism imaging
    Josef Machac
    Stephen L. Bacharach
    Timothy M. Bateman
    Jeroen J. Bax
    Robert Beanlands
    Frank Bengel
    Steven R. Bergmann
    Richard C. Brunken
    James Case
    Dominique Delbeke
    Marcelo F. DiCarli
    Ernest V. Garcia
    Richard A. Goldstein
    Robert J. Gropler
    Mark Travin
    Randolph Patterson
    Heinrich R. Schelbert
    Journal of Nuclear Cardiology, 2006, 13 (6) : e121 - e151
  • [3] WHOLE HEART DISTRIBUTION OF MYOCARDIAL PERFUSION, METABOLISM AND MYOCARDIAL VIABILITY BY POSITRON EMISSION TOMOGRAPHY
    ARAUJO, LI
    MASERI, A
    BRITISH MEDICAL BULLETIN, 1989, 45 (04) : 922 - 932
  • [4] Quantification of Myocardial Perfusion and Myocardial Perfusion Reserve by Positron Emission Tomography and Cardiovascular Magnetic Resonance Imaging
    Gerber, Bernhard L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (16) : 1556 - 1557
  • [5] Cardiac positron emission tomography: myocardial perfusion and metabolism in clinical practice
    Paul Knaapen
    Mark Lubberink
    Clinical Research in Cardiology, 2008, 97 : 791 - 796
  • [6] ASSESSMENT OF MYOCARDIAL PERFUSION, METABOLISM AND PHARMACOLOGY USING POSITRON EMISSION TOMOGRAPHY
    DESILVA, R
    CAMICI, PG
    CARDIOSCIENCE, 1992, 3 (04): : 205 - 216
  • [7] Cardiac positron emission tomography: myocardial perfusion and metabolism in clinical practice
    Knaapen, Paul
    Lubberink, Mark
    CLINICAL RESEARCH IN CARDIOLOGY, 2008, 97 (11) : 791 - 796
  • [8] INVIVO INVESTIGATION OF MYOCARDIAL PERFUSION, METABOLISM AND RECEPTORS BY POSITRON EMISSION TOMOGRAPHY
    SYROTA, A
    INTERNATIONAL JOURNAL OF MICROCIRCULATION-CLINICAL AND EXPERIMENTAL, 1989, 8 (04): : 411 - 422
  • [9] Clinical utility of inappropriate positron emission tomography myocardial perfusion imaging: Test results and cardiovascular events
    Winchester, David E.
    Chauffe, Ryan J.
    Meral, Ryan
    Daniel Nguyen
    Ryals, Scott
    Dusaj, Raman
    Shaw, Leslee
    Beyth, Rebecca J.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2015, 22 (01) : 9 - 15
  • [10] Clinical utility of inappropriate positron emission tomography myocardial perfusion imaging: Test results and cardiovascular events
    David E. Winchester
    Ryan J. Chauffe
    Ryan Meral
    Daniel Nguyen
    Scott Ryals
    Raman Dusaj
    Leslee Shaw
    Rebecca J. Beyth
    Journal of Nuclear Cardiology, 2015, 22 : 9 - 15